Skip to main content

Table 1 Epidemiologic and clinical data of clinical M. tuberculosis isolates

From: Comparative genomic analysis of Mycobacterium tuberculosis clinical isolates

Isolates Type Drug resistance profilesa Age, years Gender Geographic location Year of isolation Treatment history Clinical outcome 24 locus MIRU-VNTR profiles
Mtb562 Susceptible None 22 Male Liaoning 2010 New Cure 223224163533-454334682431
Mtb526 MDR INH, RMP, STR 39 Male Shanxi 2011 Retreated Cure 233224163533-454344672432
Mtb194 Pre-XDR INH, RMP, STR, EMB, OFX, LVX 21 Female Beijing 2010 New Cure 213224163433-243344572422
Mtb293 Pre-XDR INH, RMP, OFX, LVX, PAS, ETH 35 Female Heilongjiang 2009 n.a. n.a. 233324163523-454344682432
Mtb940 Pre-XDR INH, RMP, STR, EMB, PAS, OFX, LVX, ETH 63 Male Hebei 2010 New Cure 233324143533-254344672432
Mtb984 XDR INH, RMP, STR, EMB, OFX, LVX, KAN 72 Male Anhui 2011 Retreated Cure 233424173534-254344482432
Mtb43 XDR INH, RMP, STR, EMB, PZA, OFX, LVX, KAN, CAP, AMK, PAS, ETH 47 Male Henan 2009 Retreated Died 232224153433-454344582432
  1. n.a. = not available.
  2. aINH, isoniazid; RMP, rifampicin; STR, streptomycin; EMB, ethambutol; PZA, pyrazinamide; OFX, ofloxacin; LVX, levofloxacin; KAN, kanamycin; CAP, capreomycin; AMK, amikacin; PAS, para-amino salicylic acid; ETH, ethionamide.
\